Market Research Future (MRFR) expects the host cell protein testing market to thrive at a rate of around 5.7% from 2021 to 2027 (which is the review period). The mounting number of extensive research activities paired with the surging healthcare budget across countries would be major growth rendering factors in the coming years.
Request Free Sample Copy @ https://www.marketresearchfuture.com/sample_request/10651
Top Drivers and Deterrents
The host cell protein (HCP) testing industry will be fueled by a host of factors, including the advances in the biopharmaceutical sector along with the rise in R&D activities. The notable technical innovations in the HCP testing devices, with keen focus on elevating their quality and integrating more features, would be a favorable aspect for the global market. The dramatic surge in several chronic disorders such diabetes and as cancer and the resultant increase in R&D efforts to explore more effective treatments should also contribute to the business growth. The International Agency for Research on Cancer (IARC) reveals that the worldwide prevalence of cancer had touched close to 20.3 million cases in 2020, while claiming around 11 million lives. In addition, the American Cancer Society confirms that by 2040, the total cancer cases should reach 28.5 million with 18.3 million deaths.
Most of the vendors are focused on product and technological innovations, and obtaining approval from authoritative bodies to gain higher penetration in the host cell protein testing market. Moreover, the players are involved in strategic agreements, as well as joint ventures to foster their business standing in the worldwide market.
The impact of the COVID-19 outbreak on the healthcare business has been severe, bringing along a series of challenges including supply chain disruptions, which led to huge losses. However, the pandemic has created opportunities for the manufacturers, who are focused on raising their R&D efforts to develop treatments for the strain.
Host Cell Protein Testing Market Segmentation
The MRFR study has considered a few key segments such as type and end-users to given an extensive outline of the global market for host cell protein testing.
Major types of HCP testing are ELISA-based assays, PCR-based assays, and more. The highest share in the market belongs to the ELISA-based assays segment, as it is the primary standard for host cell protein testing.
Some of the top end users in the market are biopharmaceutical companies, Contract Research Organizations (CROs), and many others. Biopharmaceutical companies are the top segment with the largest share in view of extensive research and development activities and companies investing on the development of advanced therapeutics, which involves extensive use of HCP testing.
Host Cell Protein Testing Market Regional Insight
North America is the biggest market for host cell protein testing, with significant contributions from highly renowned firms like Charles River (US), Bio-Rad Laboratories (US), and Thermo Fisher Scientific (US), who are keenly focused on product innovations as well as new launches. Additionally, the presence of a highly established and thriving healthcare infrastructure and large-scale spending on R&D facilitates further business growth in the region.
Europe is another attractive market for host cell protein testing, housing some of the most reputed vendors including Cisbio Bioassays (France), BioGenes GmbH (Germany) and more. The region boasts of a modern healthcare infrastructure, as a result of massive spending and strong backing from the government, further fostering the market growth rate.
In Asia Pacific, rapidly improving healthcare infrastructures combine with the huge burden of several chronic disorders like diabetes and cancer have led to exhaustive R&D activities of various drugs. This factor should work in favor of the host cell protein testing industry in the region.
Host Cell Protein Testing Market Reputed Firms
Cygnus Technologies Inc. (US), BioGenes GmbH (Germany), Cytiva (US), Cisbio Bioassays (France), Thermo Fisher Scientific (US), Charles River (US), ForteBio (Pall) (US), Molecular Devices (US), Bio-Rad Laboratories (US), are the most significant host cell protein testing device and solutions developers in the global industry.
Browse Complete Report @ https://www.marketresearchfuture.com/reports/host-cell-protein-testing-market-10651
About Market Research Future:
Market Research Future (MRFR) is a global market research company that takes pride in its services, offering a complete and accurate analysis with regard to diverse markets and consumers worldwide. Market Research Future has the distinguished objective of providing the optimal quality research and granular research to clients. Our market research studies by products, services, technologies, applications, end users, and market players for global, regional, and country level market segments, enable our clients to see more, know more, and do more, which help answer your most important questions.